Can financial payments incentivize short-term smoking cessation in orthopaedic trauma patients? Evidence from a discrete choice experiment.
Journal
Health economics review
ISSN: 2191-1991
Titre abrégé: Health Econ Rev
Pays: Germany
ID NLM: 101583209
Informations de publication
Date de publication:
26 Apr 2021
26 Apr 2021
Historique:
received:
27
10
2020
accepted:
18
04
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
28
4
2021
Statut:
epublish
Résumé
Smoking increases the risk of complications and related costs after an orthopaedic fracture. Research in other populations suggests that a one-time payment may incentivize smoking cessation. However, little is known on fracture patients' willingness to accept financial incentives to stop smoking; and the level of incentive required to motivate smoking cessation in this population. This study aimed to estimate the financial threshold required to motivate fracture patients to stop smoking after injury. This cross-sectional study utilized a discrete choice experiment (DCE) to elicit patient preferences towards financial incentives and reduced complications associated with smoking cessation. We presented participants with 12 hypothetical options with several attributes with varying levels. The respondents' data was used to determine the utility of each attribute level and the relative importance associated with each attribute. Of the 130 enrolled patients, 79% reported an interest in quitting smoking. We estimated the financial incentive to be of greater relative importance (ri) (45%) than any of the included clinical benefits of smoking cessations (deep infection (ri: 24%), bone healing complications (ri: 19%), and superficial infections (ri: 12%)). A one-time payment of $800 provided the greatest utility to the respondents (0.64, 95% CI: 0.36 to 0.93), surpassing the utility associated with a single $1000 financial incentive (0.36, 95% CI: 0.18 to 0.55). Financial incentives may be an effective tool to promote smoking cessation in the orthopaedic trauma population. The findings of this study define optimal payment thresholds for smoking cessation programs.
Sections du résumé
BACKGROUND
BACKGROUND
Smoking increases the risk of complications and related costs after an orthopaedic fracture. Research in other populations suggests that a one-time payment may incentivize smoking cessation. However, little is known on fracture patients' willingness to accept financial incentives to stop smoking; and the level of incentive required to motivate smoking cessation in this population. This study aimed to estimate the financial threshold required to motivate fracture patients to stop smoking after injury.
METHODS
METHODS
This cross-sectional study utilized a discrete choice experiment (DCE) to elicit patient preferences towards financial incentives and reduced complications associated with smoking cessation. We presented participants with 12 hypothetical options with several attributes with varying levels. The respondents' data was used to determine the utility of each attribute level and the relative importance associated with each attribute.
RESULTS
RESULTS
Of the 130 enrolled patients, 79% reported an interest in quitting smoking. We estimated the financial incentive to be of greater relative importance (ri) (45%) than any of the included clinical benefits of smoking cessations (deep infection (ri: 24%), bone healing complications (ri: 19%), and superficial infections (ri: 12%)). A one-time payment of $800 provided the greatest utility to the respondents (0.64, 95% CI: 0.36 to 0.93), surpassing the utility associated with a single $1000 financial incentive (0.36, 95% CI: 0.18 to 0.55).
CONCLUSIONS
CONCLUSIONS
Financial incentives may be an effective tool to promote smoking cessation in the orthopaedic trauma population. The findings of this study define optimal payment thresholds for smoking cessation programs.
Identifiants
pubmed: 33903947
doi: 10.1186/s13561-021-00313-3
pii: 10.1186/s13561-021-00313-3
pmc: PMC8077692
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Références
J Arthroplasty. 2019 Feb;34(2):385-396.e4
pubmed: 30385090
N Engl J Med. 2009 Feb 12;360(7):699-709
pubmed: 19213683
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
BMJ. 2000 Jun 3;320(7248):1530-3
pubmed: 10834905
Ann Surg. 2008 Nov;248(5):739-45
pubmed: 18948800
Int J Environ Res Public Health. 2018 Dec 13;15(12):
pubmed: 30551632
J Trauma. 2009 Dec;67(6):1389-92
pubmed: 19704386
Soc Sci Med. 2019 Jul;232:340-350
pubmed: 31129504
Foot Ankle Int. 2019 Oct;40(10):1226-1232
pubmed: 31423824
J Orthop Trauma. 2017 Aug;31(8):e252-e254
pubmed: 28737593
Foot Ankle Int. 2015 May;36(5):488-93
pubmed: 25583954
Health Psychol. 2013 Sep;32(9):950-7
pubmed: 24001245
Am J Orthop (Belle Mead NJ). 2002 Sep;31(9):518-21
pubmed: 12650537
ANZ J Surg. 2017 Jan;87(1-2):55-59
pubmed: 27619072
Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937
pubmed: 28108823
Orphanet J Rare Dis. 2021 Jan 20;16(1):36
pubmed: 33472673
Medicine (Baltimore). 2018 Feb;97(7):e9901
pubmed: 29443762
Am J Med. 2020 Jun;133(6):741-749
pubmed: 31982494
Med J Aust. 1983 Oct 29;2(9):425-9
pubmed: 6633406
MMWR Morb Mortal Wkly Rep. 2014 Jan 17;63(2):29-34
pubmed: 24430098
N Engl J Med. 1999 Mar 4;340(9):685-91
pubmed: 10053177
BMJ. 2004 Feb 14;328(7436):360-1
pubmed: 14962852
J Orthop Trauma. 2016 Mar;30(3):149-55
pubmed: 26544953
BMC Health Serv Res. 2021 Jan 6;21(1):17
pubmed: 33407395
Anesthesiology. 2006 Feb;104(2):356-67
pubmed: 16436857
J Trauma. 2007 Jan;62(1):174-83
pubmed: 17215751
Am J Prev Med. 2008 Feb;34(2):102-11
pubmed: 18201639
Soc Sci Med. 2019 May;228:181-193
pubmed: 30925392
Ann Surg. 2003 Jul;238(1):1-5
pubmed: 12832959
J Bone Joint Surg Am. 2013 May 1;95(9):850-9
pubmed: 23636193
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
JAMA Netw Open. 2019 Aug 2;2(8):e199951
pubmed: 31441940
Health Serv Res. 2018 Dec;53(6):5016-5034
pubmed: 29896800
J Bone Joint Surg Am. 2014 Apr 16;96(8):674-81
pubmed: 24740664
Drug Alcohol Rev. 2014 Sep;33(5):548-54
pubmed: 25091934
BMJ Open. 2016 Nov 14;6(11):e010303
pubmed: 28186922
Drug Ther Bull. 2019 Jan;57(1):8
pubmed: 30567851
Prev Med. 2012 Nov;55 Suppl:S24-32
pubmed: 22525802
BMC Public Health. 2020 Jun 1;20(1):828
pubmed: 32487041
Cochrane Database Syst Rev. 2019 Feb 20;2:CD013272
pubmed: 30784046
J Bone Joint Surg Br. 2000 Jul;82(5):655-8
pubmed: 10963160
Ann Chir Gynaecol. 1993;82(4):254-62
pubmed: 8122874
J Bone Joint Surg Am. 2010 Jun;92(6):1335-42
pubmed: 20516308
Respir Care. 2008 Sep;53(9):1217-22
pubmed: 18807274
N Engl J Med. 2015 May 28;372(22):2108-17
pubmed: 25970009
J Orthop Trauma. 2011 Dec;25(12):748-55
pubmed: 21886001
J Arthroplasty. 2014 May;29(5):929-32
pubmed: 24140271
Foot (Edinb). 2021 Mar;46:101735
pubmed: 33168350
Am J Orthop (Belle Mead NJ). 2007 Apr;36(4):207-9
pubmed: 17515188
Injury. 2011 Dec;42(12):1435-42
pubmed: 21665205
Value Health. 2015 Mar;18(2):224-33
pubmed: 25773558
Am J Med. 2011 Feb;124(2):144-154.e8
pubmed: 21295194
BMC Med Res Methodol. 2019 Jul 4;19(1):138
pubmed: 31272393
J Trauma. 2011 Feb;70(2):352-6; discussion 356-7
pubmed: 21307734
J Orthop Trauma. 2005 Mar;19(3):151-7
pubmed: 15758667
Injury. 2016 Jun;47(6):1206-11
pubmed: 27090096
Ann Fam Med. 2008 Mar-Apr;6(2):107-15
pubmed: 18332402
Cochrane Database Syst Rev. 2012 Oct 17;10:CD008286
pubmed: 23076944
Cochrane Database Syst Rev. 2019 Jul 17;7:CD004307
pubmed: 31313293
J Am Coll Cardiol. 2016 Aug 23;68(8):777-85
pubmed: 27539168